BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15192043)

  • 1. Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action.
    Takeda M; Otsuka F; Nakamura K; Inagaki K; Suzuki J; Miura D; Fujio H; Matsubara H; Date H; Ohe T; Makino H
    Endocrinology; 2004 Sep; 145(9):4344-54. PubMed ID: 15192043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
    Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC
    Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells.
    Zhang S; Fantozzi I; Tigno DD; Yi ES; Platoshyn O; Thistlethwaite PA; Kriett JM; Yung G; Rubin LJ; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L740-54. PubMed ID: 12740218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein signaling in articular chondrocyte differentiation.
    Nishihara A; Fujii M; Sampath TK; Miyazono K; Reddi AH
    Biochem Biophys Res Commun; 2003 Feb; 301(2):617-22. PubMed ID: 12565908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory roles of bone morphogenetic proteins and glucocorticoids in catecholamine production by rat pheochromocytoma cells.
    Kano Y; Otsuka F; Takeda M; Suzuki J; Inagaki K; Miyoshi T; Miyamoto M; Otani H; Ogura T; Makino H
    Endocrinology; 2005 Dec; 146(12):5332-40. PubMed ID: 16150914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells.
    Inagaki K; Otsuka F; Suzuki J; Kano Y; Takeda M; Miyoshi T; Otani H; Mimura Y; Ogura T; Makino H
    Endocrinology; 2006 Jun; 147(6):2681-9. PubMed ID: 16527843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
    Upton PD; Davies RJ; Tajsic T; Morrell NW
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.
    Otani H; Otsuka F; Inagaki K; Takeda M; Miyoshi T; Suzuki J; Mukai T; Ogura T; Makino H
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1513-25. PubMed ID: 17244894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells.
    Sheares KK; Jeffery TK; Long L; Yang X; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L919-27. PubMed ID: 15220111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
    Yu PB; Beppu H; Kawai N; Li E; Bloch KD
    J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
    Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells.
    Moore RK; Otsuka F; Shimasaki S
    J Biol Chem; 2003 Jan; 278(1):304-10. PubMed ID: 12419820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.
    Fantozzi I; Huang W; Zhang J; Zhang S; Platoshyn O; Remillard CV; Thistlethwaite PA; Yuan JX
    Exp Lung Res; 2005 Oct; 31(8):783-806. PubMed ID: 16368652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of MAP kinase by the BMP-4/TAK1 pathway in Xenopus ectoderm.
    Goswami M; Uzgare AR; Sater AK
    Dev Biol; 2001 Aug; 236(2):259-70. PubMed ID: 11476570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
    de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM
    J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.